David Zaccardelli
Chief Executive Officer bei VERONA PHARMA PLC
Vermögen: 144 Mio $ am 31.03.2024
Aktive Positionen von David Zaccardelli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERONA PHARMA PLC | Director/Board Member | 01.02.2020 | - |
Chief Executive Officer | 01.02.2020 | - | |
President | 01.02.2020 | - | |
Evecxia, Inc.
Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Director/Board Member | 01.06.2016 | - |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Director/Board Member | 29.04.2021 | - |
Karriereverlauf von David Zaccardelli
Ehemalige bekannte Positionen von David Zaccardelli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | Director/Board Member | 01.06.2015 | 01.01.2021 |
MELINTA THERAPEUTICS, INC. | Director/Board Member | 01.08.2016 | 20.04.2020 |
Independent Dir/Board Member | 01.08.2016 | 20.04.2020 | |
DOVA PHARMACEUTICALS, INC. | Director/Board Member | - | 12.11.2019 |
Chief Executive Officer | 16.12.2018 | 12.11.2019 | |
President | 16.12.2018 | 12.11.2019 | |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Director/Board Member | 10.08.2016 | 01.11.2017 |
Chief Executive Officer | 12.12.2016 | 01.11.2017 | |
UNITED THERAPEUTICS CORPORATION | Chief Operating Officer | 01.01.2004 | 26.06.2016 |
Corporate Officer/Principal | 01.01.2008 | 01.01.2015 | |
Bausch & Lomb Pharmaceuticals, Inc.
Bausch & Lomb Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb Pharmaceuticals, Inc. develops, manufactures, and markets eye health products. It offers products such as contact lens, lens care, pharmaceuticals, cataract and vitreoretinal, and refractive surgery. The company is headquartered in Tampa, FL. | Chief Tech/Sci/R&D Officer | 01.01.1996 | 01.01.1997 |
Ausbildung von David Zaccardelli
University of Michigan | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 7 |
Chief Executive Officer | 3 |
President | 2 |
Sektoral
Health Technology | 8 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
VERONA PHARMA PLC | Health Technology |
Private Unternehmen | 7 |
---|---|
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | Commercial Services |
Bausch & Lomb Pharmaceuticals, Inc.
Bausch & Lomb Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb Pharmaceuticals, Inc. develops, manufactures, and markets eye health products. It offers products such as contact lens, lens care, pharmaceuticals, cataract and vitreoretinal, and refractive surgery. The company is headquartered in Tampa, FL. | Health Technology |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Health Technology |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
Evecxia, Inc.
Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Commercial Services |
- Börse
- Insiders
- David Zaccardelli
- Erfahrung